AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (December 7, 2006). doi:10.1152/ajpregu.00634.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/4/R1563    most recent
00634.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johannsson, E.
Right arrow Articles by Iversen, P. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johannsson, E.
Right arrow Articles by Iversen, P. O.
Submitted on September 6, 2006
Accepted on December 2, 2006

Increase in matrix metalloproteinases from endothelial cells exposed to umbilical cord plasma from high birth weight newborns

Erlingur Johannsson1, Tore Henriksen2, and Per Ole Iversen3*

1 Center for Sport and Health Sciences, Iceland University of Education, Laugarvatn, Iceland
2 Department of Gynecology and Obstetrics, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway
3 Department of Nutrition, University of Oslo, Oslo, Norway

* To whom correspondence should be addressed. E-mail: poiversen{at}hotmail.com.

Large for gestational age infants have increased risk of developing the metabolic syndrome and cardiovascular disease in child- and adulthood. The vascular endothelium is a target site in the pathogenesis of many cardiovascular disorders. The matrix metalloproteinases (MMP) are important modulators of the extracellular matrix and serve as markers of these disorders. Here we asked if umbilical cord plasma of high birth weight (HBW, > 4 kg) infants could modulate functional properties of human umbilical vein endothelial cells (HUVEC) compared with plasma from normal birth weight (NBW, 3.1-3.6 kg) infants. To test this, HUVECs were exposed for 48 h to 20% venous cord plasma from HBW or NBW infants. The MMP-activity in supernatants of HUVECs exposed to HBW- plasma was nearly 3 times higher (P < 0.05) than that obtained with NBW-plasma. MMP-9, but not MMP-2, protein concentration and mRNA expression were enhanced in HBW (P < 0.05). With specific blockers MMP-activity and mRNA-MMP-9 were inhibited by about 60-70%. Cord lipid- and insulin concentrations were similar (P > 0.05) among the two groups. We could not detect any significant differences between the two groups in the concentrations of proinflammatory cytokines or specific tissue inhibitors of MMP in plasma or HUVEC supernatants. In conclusion, cord plasma from HBW infants induced more MMP-9 in HUVECs compared with cord plasma from NBW infants. Although not identified, cord plasma of HBW infants may contain factors that increase endothelial cell MMP. These findings may indicate an association between fetal nutritional conditions and endothelial cell functions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.